OBJECTIVE: to investigate whether the association between blood pressure and clinical outcomes is different in older adults with and without frailty, using observational studies. METHODS: MEDLINE, EMBASE and CINAHL were searched from 1st January 2000 to 13th June 2018. PROSPERO CRD42017081635. We included all observational studies reporting clinical outcomes in older adults with an average age over 65 years living in the community with and without treatment that measured blood pressure and frailty using validated methods. Two independent reviewers evaluated study quality and risk of bias using the ROBANS tool. We used generic inverse variance modelling to pool risks of all-cause mortality adjusted for age and sex. RESULTS: nine observational studies involving 21,906 older adults were included, comparing all-cause mortality over a mean of six years. Fixed effects meta-analysis of six studies demonstrated that in people with frailty, there was no mortality difference associated with systolic blood pressure <140 mm Hg compared to systolic blood pressure >140 mm Hg (HR 1.02, 95% CI 0.90 to 1.16). In the absence of frailty, systolic blood pressure <140 mm Hg was associated with lower risk of death compared to systolic blood pressure >140 mm Hg (HR 0.86, 95% CI 0.77 to 0.96). CONCLUSIONS: evidence from observational studies demonstrates no mortality difference for older people with frailty whose systolic blood pressure is <140 mm Hg, compared to those with a systolic blood pressure >140 mm Hg. Current evidence fails to capture the complexities of blood pressure measurement, and the association with non-fatal outcomes.
OBJECTIVE: to investigate whether the association between blood pressure and clinical outcomes is different in older adults with and without frailty, using observational studies. METHODS: MEDLINE, EMBASE and CINAHL were searched from 1st January 2000 to 13th June 2018. PROSPERO CRD42017081635. We included all observational studies reporting clinical outcomes in older adults with an average age over 65 years living in the community with and without treatment that measured blood pressure and frailty using validated methods. Two independent reviewers evaluated study quality and risk of bias using the ROBANS tool. We used generic inverse variance modelling to pool risks of all-cause mortality adjusted for age and sex. RESULTS: nine observational studies involving 21,906 older adults were included, comparing all-cause mortality over a mean of six years. Fixed effects meta-analysis of six studies demonstrated that in people with frailty, there was no mortality difference associated with systolic blood pressure <140 mm Hg compared to systolic blood pressure >140 mm Hg (HR 1.02, 95% CI 0.90 to 1.16). In the absence of frailty, systolic blood pressure <140 mm Hg was associated with lower risk of death compared to systolic blood pressure >140 mm Hg (HR 0.86, 95% CI 0.77 to 0.96). CONCLUSIONS: evidence from observational studies demonstrates no mortality difference for older people with frailty whose systolic blood pressure is <140 mm Hg, compared to those with a systolic blood pressure >140 mm Hg. Current evidence fails to capture the complexities of blood pressure measurement, and the association with non-fatal outcomes.
Authors: Kaiyan Hu; Qi Zhou; Yanbiao Jiang; Zhizhong Shang; Fan Mei; Qianqian Gao; Fei Chen; Li Zhao; Mengyao Jiang; Bin Ma Journal: Biomed Res Int Date: 2021-01-27 Impact factor: 3.411
Authors: Alex Hall; Elisabeth Boulton; Patience Kunonga; Gemma Spiers; Fiona Beyer; Peter Bower; Dawn Craig; Chris Todd; Barbara Hanratty Journal: Palliat Med Date: 2021-09-14 Impact factor: 4.762
Authors: Luigina Guasti; Marco Ambrosetti; Marco Ferrari; Franca Marino; Marc Ferrini; Isabella Sudano; Maria Laura Tanda; Iris Parrini; Riccardo Asteggiano; Marco Cosentino Journal: Drugs Aging Date: 2022-07-29 Impact factor: 4.271
Authors: Job van Steenkiste; Michael C van Herwerden; Dolf Weller; Christiaan J van den Bout; Rikje Ruiter; Jan G den Hollander; Rachida El Moussaoui; Gert T Verhoeven; Charlotte van Noord; Marinus A van den Dorpel Journal: Heart Lung Date: 2021-05-25 Impact factor: 2.210
Authors: Peter Hanlon; Neave Corcoran; Guy Rughani; Anoop S V Shah; Frances S Mair; Bruce Guthrie; Joanne P Renton; David A McAllister Journal: Lancet Healthy Longev Date: 2021-07
Authors: Nicholas R Evans; Oliver M Todd; Jatinder S Minhas; Patricia Fearon; George W Harston; Jonathan Mant; Gillian Mead; Jonathan Hewitt; Terence J Quinn; Elizabeth A Warburton Journal: Int J Stroke Date: 2021-08-04 Impact factor: 5.266